Natco Pharma informs about disclosure

20 Aug 2021 Evaluate

Natco Pharma has informed that it enclosed the disclosure titled ‘Legal update on Ibrutinib’ under Regulation 30 of SEBI (LODR) Regulations 2015.

The above information is a part of company’s filings submitted to BSE.


Natco Pharma Share Price

814.35 -17.40 (-2.09%)
27-Jan-2026 11:29 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1241.50
Cipla 1308.00
Zydus Lifesciences 891.50
Lupin 2142.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×